Merck had approached a small biotech research company with a proposal to buy Merck rights to a new drug that promises to treat obesity and lower cholesterol. The drug is in the middle of the first stage of the approval process FDA. Patent Harlow, head of licensing, has been leading the investigation team of the company Merck. The meeting is scheduled for tomorrow, which prompted Merck to be prepared. "Hide
by Sherwood C. Frey, Samuel E Bodily Source: University of Virginia Darden School Foundation 5 pages. Publication Date: July 9, 2002. Prod. #: UV3844-PDF-ENG
Related Case Solutions & Analyses:
Abbott and the AIDS Crisis (C): What Lies Ahead
Pacesetter Riverdale and the Illinois Campaign for Affordable Housing
Fitness Anywhere
TiVo
Alacrity Housing Chennai (B)
Ultra: The Quest for Leadership (B)
Go Beyond Investing
Evoe Spring Spa: A Positioning Dilemma
Leading Organic Growth: Module Caselets
Tale of the Lynx (B)
